Brief: Oramed Pharmaceuticals Has $160 Million In Cash And Investments As Of Sept 30
21/12/2022 13:26
Dec 21 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED PHARMACEUTICALS INC - $160 MILLION IN CASH AND
INVESTMENTS (AS OF SEPTEMBER 30, 2022)
Source text for Eikon: ID:nPnn0KL1a
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results